{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T18:06:14Z","timestamp":1760897174037},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[1998,8,1]],"date-time":"1998-08-01T00:00:00Z","timestamp":901929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T00:00:00Z","timestamp":1578441600000},"content-version":"vor","delay-in-days":7830,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1998,8]]},"DOI":"10.1023\/a:1008439620513","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T14:30:06Z","timestamp":1040567406000},"page":"835-843","source":"Crossref","is-referenced-by-count":40,"title":["Report of the European Task Force on Lymphomas: Workshop on peripheral T-cell lymphomas"],"prefix":"10.1016","volume":"9","author":[{"given":"E.","family":"Campo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Gaulard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Zucca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.S.","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.L.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Diebold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Schlegelberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.C.","family":"Feller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Delsol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Gisselbrecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Montserrat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1023\/A:1008439620513_bb0010","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","article-title":"A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin\u2019s lymphoma","volume":"89","author":"The non-Hodgkin\u2019s lymphoma classification project","year":"1997","journal-title":"Blood"},{"key":"10.1023\/A:1008439620513_bb0015","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised european\u2013american classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"10.1023\/A:1008439620513_bb0020","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1182\/blood.V83.2.505.505","article-title":"Cytogenetic findings in peripheral T-cell lymphomas as a basis for distinguishing low-grade and high-grade lymphomas","volume":"83","author":"Schlegelberger","year":"1994","journal-title":"Blood"},{"key":"10.1023\/A:1008439620513_bb0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0165-4608(94)90040-X","article-title":"Recurrent chromosome abnormalities in peripheral T-cell lymphomas","volume":"78","author":"Schlegelberger","year":"1994","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1023\/A:1008439620513_bb0030","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1182\/blood.V84.8.2640.2640","article-title":"Detection of aberrant clones in nearly all cases of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma by combined interphase and metaphase cytogenetics","volume":"84","author":"Schlegelberger","year":"1994","journal-title":"Blood"},{"key":"10.1023\/A:1008439620513_bb0035","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1200\/JCO.1996.14.2.593","article-title":"Significance of cytogenetic findings for the clinical outcome in patients with T-cell lymphoma of AILD-type","volume":"14","author":"Schlegelberger","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008439620513_bb0040","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1182\/blood.V66.4.848.bloodjournal664848","article-title":"The expression of the Hodgkin\u2019s disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed\u2013Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells","volume":"66","author":"Stein","year":"1985","journal-title":"Blood"},{"key":"10.1023\/A:1008439620513_bb0045","first-page":"59","article-title":"Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis","volume":"130","author":"Delsol","year":"1988","journal-title":"Am J Pathol"},{"key":"10.1023\/A:1008439620513_bb0050","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/bjc.1991.299","article-title":"Antibody BNH9 detects red blood cell-related antigens on anaplastic large cell (CD30+) lymphomas","volume":"64","author":"Delsol","year":"1991","journal-title":"Br J Cancer"},{"key":"10.1023\/A:1008439620513_bb0055","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1182\/blood.V89.4.1394","article-title":"Detection of Anaplastic Lymphoma Kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1","volume":"89","author":"Pulford","year":"1997","journal-title":"Blood"},{"key":"10.1023\/A:1008439620513_bb0060","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1182\/blood.V84.8.2467.2467","article-title":"Clinicopathologic features and treatment outcome of children with large-cell lymphoma and the t(2;5)(p23; q35)","volume":"84","author":"Sandlund","year":"1994","journal-title":"Blood"},{"key":"10.1023\/A:1008439620513_bb0065","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/00000478-199004000-00001","article-title":"Morphology in Ki-1 (CD30)-positive non-Hodgkin\u2019s lymphomas correlated with clinical features and the presence of a unique chromosomal abnormality","volume":"14","author":"Bitter","year":"1990","journal-title":"Am J Surg Pathol"},{"key":"10.1023\/A:1008439620513_bb0070","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1182\/blood.V86.5.1954.bloodjournal8651954","article-title":"Anaplastic large cell lymphomas expressing the novel chimeric protein P80 NPM\/ALK: A distinct clinicopathologic entity","volume":"85","author":"Shiota","year":"1995","journal-title":"Blood"},{"key":"10.1023\/A:1008439620513_bb0075","first-page":"343","article-title":"The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large-cell lymphoma associated with 2p23\/ALK rearrangements","volume":"151","author":"Pittaluga","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1023\/A:1008439620513_bb0080","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1097\/00000478-199601000-00012","article-title":"Report of the workshop on nasal and related extranodal angiocentricT\/Natural Killer cell lymphomas. Definition, differential diagnosis and epidemiology","volume":"20","author":"Jaffe","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1023\/A:1008439620513_bb0085","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood.V87.4.1466.bloodjournal8741466","article-title":"PI CD5- CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas","volume":"87","author":"Emile","year":"1996","journal-title":"Blood"},{"key":"10.1023\/A:1008439620513_bb0090","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1182\/blood.V89.12.4501","article-title":"Nonnasal lymphoma expressing the natural killer cell marker CD56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm","volume":"89","author":"Chan","year":"1997","journal-title":"Blood"},{"key":"10.1023\/A:1008439620513_bb0095","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/(SICI)1096-9896(199712)183:4<432::AID-PATH942>3.0.CO;2-4","article-title":"Cytotoxic protein expression in natural killer cell lymphomas and in \u03b1\/\u03b2 and \u03b3\/\u03b4 peripheral T-cell lymphomas","volume":"183","author":"Boulland","year":"1997","journal-title":"J Pathol"},{"key":"10.1023\/A:1008439620513_bb0100","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1182\/blood.V90.10.4099","article-title":"The role of Mig the monokine induced by interferon-y and IP-10, the interferon-\u03b3 inducible protein 10 in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease","volume":"90","author":"Teruya-Feldstein","year":"1997","journal-title":"Blood"},{"key":"10.1023\/A:1008439620513_bb0105","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00000478-199305000-00001","article-title":"Primary lymphoma of the small intestine: A clinicopathologic study of 119 cases","volume":"17","author":"Domizio","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"10.1023\/A:1008439620513_bb0110","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0046-8177(98)90122-8","article-title":"Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes","volume":"29","author":"Kumar","year":"1998","journal-title":"Hum Pathol"},{"key":"10.1023\/A:1008439620513_bb0115","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1056\/NEJM199110103251506","article-title":"A subcutaneous delta-positive T-cell lymphoma that produces interferon gamma","volume":"325","author":"Burg","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1023\/A:1008439620513_bb0120","first-page":"841","article-title":"Hepatosplenic \u03b3\/\u03b4 T-cell lymphoma: Clinical and biological characteristics of a recently recognized entity which is fatal","volume":"25","author":"Gaulard","year":"1997","journal-title":"Exp Hematol"},{"key":"10.1023\/A:1008439620513_bb0125","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1182\/blood.V88.11.4265.bloodjournal88114265","article-title":"Hepatosplenic T-cell lymphoma. A distinct clinicopathologic entity of cytotoxic \u03b3\/\u03b4 T-cell origin","volume":"88","author":"Cooke","year":"1996","journal-title":"Blood"},{"key":"10.1023\/A:1008439620513_bb0130","first-page":"1723","article-title":"Nonhepatosplenic \u03b3\/\u03b4 T-cell lymphoma: A subset of cytotoxic lymphomas with mucosal or skin localization","volume":"91","author":"Arnulf","year":"1998","journal-title":"Blood"},{"key":"10.1023\/A:1008439620513_bb0135","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1200\/JCO.1991.9.8.1426","article-title":"Similar outcome of treatment of B-cell and T-cell diffuse large-cell lymphomas: The Stanford experience","volume":"9","author":"Kwak","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008439620513_bb0140","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1200\/JCO.1989.7.6.725","article-title":"Direct comparisons of peripheral T-cell lymphoma with diffuse B-cell lymphoma of comparable histological grades should peripheral T-cell lymphoma be considered separately?","volume":"7","author":"Cheng","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1008439620513_bb0145","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1182\/blood.V89.12.4514","article-title":"Evaluation of the revised European-American lymphoma classification confirms the clinical relevance of immonophenotype in 560 cases of aggressive non-Hodgkin\u2019s lymphoma","volume":"89","author":"Melnyk","year":"1997","journal-title":"Blood"},{"key":"10.1023\/A:1008439620513_bb0150","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1182\/blood.V72.2.436.436","article-title":"The prognostic significance of the immunotype in diffuse large-cell lymphoma: A comparative study of the T-cell and B-cell phenotype","volume":"72","author":"Lippman","year":"1988","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1023\/A:1008439620513_bb0155","first-page":"293a","article-title":"Prognostic significance of T-cell phenotype in aggressive non-Hodgkin\u2019s lymphoma","volume":"88","author":"Gisselbrecht","year":"1996","journal-title":"Blood"},{"key":"10.1023\/A:1008439620513_bb0160","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1182\/blood.V87.10.4358.bloodjournal87104358","volume":"87","author":"Pittaluga","year":"1996","journal-title":"Blood"},{"key":"10.1023\/A:1008439620513_bb0165","first-page":"354","article-title":"EORTC classification for primary cutaneous lymphomas: A proposal from the cutaneous lymphoma study group of the European Organization for Research and Treatment of Cancer","volume":"90","author":"Willemze","year":"1997","journal-title":"Blood"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419559567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419559567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/9\/8\/835\/19481928\/9-8-835.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T22:57:09Z","timestamp":1582239429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419559567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1998,8]]}},"alternative-id":["S0923753419559567"],"URL":"https:\/\/doi.org\/10.1023\/a:1008439620513","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1998,8]]}}}